Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: BioGaia AB

Capitalization 1.15TCr 121.6Cr 106.29Cr 96Cr 92Cr 167.08Cr 11TCr 173.68Cr 454.62Cr 5.37TCr 456.31Cr 446.67Cr 19TCr P/E ratio 2025
32.3x
P/E ratio 2026 * 27.3x
Enterprise value 1.07TCr 112.94Cr 99Cr 89Cr 85Cr 155.18Cr 10TCr 161.31Cr 422.24Cr 4.99TCr 423.81Cr 414.86Cr 18TCr EV / Sales 2025
6.98x
EV / Sales 2026 * 6.46x
Free-Float
87.96%
Yield 2025 *
4.59%
Yield 2026 * 3.7%
1 day+2.62%
1 week+2.81%
Current month+1.52%
1 month+9.35%
3 months+16.01%
6 months+9.67%
Current year+6.78%
1 week 107.2
Extreme 107.2
114.3
1 month 101.2
Extreme 101.2
114.3
Current year 97.5
Extreme 97.5
119.8
1 year 93.2
Extreme 93.2
119.8
3 years 87.95
Extreme 87.95
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 40
Extreme 40
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Change 5d. change 1-year change 3-years change Capi.($)
+2.62%+2.81%-1.73%+20.15% 121.6Cr
-0.11%-1.85%+9.57%-0.87% 7.65TCr
-1.19%-0.56%+38.21%+218.77% 5.44TCr
-2.03%+59.20%+59.20%+59.20% 4.91TCr
-0.01%-3.58%-43.25%-50.21% 4.75TCr
-1.81%-1.80%+29.70%-29.78% 2.66TCr
-1.55%+0.08%+53.24%-64.46% 2.08TCr
+0.55%-3.54%+36.67%+26.46% 1.84TCr
-1.10%-2.94%+105.73%+106.25% 1.79TCr
-1.69%-1.01%+30.17%+56.90% 1.37TCr
Average -0.63%-1.16%+31.75%+34.24% 3.26TCr
Weighted average by Cap. -0.87%-1.46%+26.19%+41.12%

Financials

2025 2026 *
Net sales 149.1Cr 16Cr 14Cr 12Cr 12Cr 22Cr 1.46TCr 23Cr 59Cr 698.39Cr 59Cr 58Cr 2.52TCr 164.4Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 25Cr 65Cr 770.05Cr 65Cr 64Cr 2.78TCr
Net income 31Cr 3.3Cr 2.88Cr 2.6Cr 2.49Cr 4.53Cr 304.91Cr 4.71Cr 12Cr 145.67Cr 12Cr 12Cr 526.15Cr 42Cr 4.45Cr 3.89Cr 3.52Cr 3.36Cr 6.12Cr 411.78Cr 6.36Cr 17Cr 196.73Cr 17Cr 16Cr 710.55Cr
Net Debt -82Cr -8.66Cr -7.57Cr -6.84Cr -6.54Cr -12Cr -801.01Cr -12Cr -32Cr -382.68Cr -32Cr -32Cr -1.38TCr -85Cr -9.04Cr -7.9Cr -7.14Cr -6.83Cr -12Cr -836.3Cr -13Cr -34Cr -399.55Cr -34Cr -33Cr -1.44TCr
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
242
Date Price Change Volume
13/26/13 113.40 kr +2.62% 2,49,073
12/26/12 110.50 kr +0.64% 2,80,661
11/26/11 109.80 kr -1.61% 1,77,520
10/26/10 111.60 kr +1.82% 2,13,934
09/26/09 109.60 kr -0.63% 1,63,888
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
113.40SEK
Average target price
140.00SEK
Spread / Average Target
+23.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIOG B Stock
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW